WO2009034029A3 - 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten - Google Patents
1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten Download PDFInfo
- Publication number
- WO2009034029A3 WO2009034029A3 PCT/EP2008/061771 EP2008061771W WO2009034029A3 WO 2009034029 A3 WO2009034029 A3 WO 2009034029A3 EP 2008061771 W EP2008061771 W EP 2008061771W WO 2009034029 A3 WO2009034029 A3 WO 2009034029A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- heterocyclylpiperidines
- cgrp antagonists
- substituted
- salts
- hydrates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Gegenstand der vorliegenden Erfindung sind neue CGRP-Antagonisten der allgemeinen Formel (I), in der A, X, R1, R2 und R3 wie in der Beschreibung erwähnt definiert sind, deren Tautomere, deren Isomere, deren Diastereomere, deren Enantiomere, deren Hydrate, deren Gemische und deren Salze sowie die Hydrate der Salze, insbesondere deren physiologisch verträgliche Salze mit anorganischen oder organischen Säuren oder Basen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07115904 | 2007-09-07 | ||
EP07115904.0 | 2007-09-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009034029A2 WO2009034029A2 (de) | 2009-03-19 |
WO2009034029A3 true WO2009034029A3 (de) | 2009-07-09 |
Family
ID=39205275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/061771 WO2009034029A2 (de) | 2007-09-07 | 2008-09-05 | 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009034029A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0817835A2 (pt) | 2007-10-18 | 2015-03-31 | Boehringer Ingelheim Int | Antagonistas cgrp |
EP2065381A1 (de) | 2007-10-18 | 2009-06-03 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP Antagonisten |
JP5385297B2 (ja) | 2007-11-22 | 2014-01-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規化合物 |
SG11201406311UA (en) * | 2012-04-05 | 2014-11-27 | Chdi Foundation Inc | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
EP3049389B1 (de) * | 2013-09-26 | 2019-08-07 | CHDI Foundation, Inc. | Kynurenin-3-monooxygenase-hemmer, pharmazeutische zusammensetzungen und verfahren zur verwendung davon |
JP2016536350A (ja) | 2013-09-26 | 2016-11-24 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | キヌレニン−3−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法 |
GB201707938D0 (en) | 2017-05-17 | 2017-06-28 | Univ Sheffield | Compounds |
CN112624979A (zh) * | 2019-10-09 | 2021-04-09 | 浙江瑞博制药有限公司 | 一种苯并咪唑化合物的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2065426A1 (de) * | 1969-10-27 | 1973-07-19 | Sumitomo Chemical Co | Phenylbutanol-derivate, ihre salze, verfahren zu ihrer herstellung und die verbindungen enthaltende arzneimittel |
US4455422A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and pharmaceutical composition containing the same |
WO2001032649A1 (de) * | 1999-10-29 | 2001-05-10 | Boehringer Ingelheim Pharma Kg | Arylalkane, arylalkene und aryl-azaalkane, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
WO2001032648A1 (de) * | 1999-10-29 | 2001-05-10 | Boehringer Ingelheim Pharma Kg | Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
-
2008
- 2008-09-05 WO PCT/EP2008/061771 patent/WO2009034029A2/de active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2065426A1 (de) * | 1969-10-27 | 1973-07-19 | Sumitomo Chemical Co | Phenylbutanol-derivate, ihre salze, verfahren zu ihrer herstellung und die verbindungen enthaltende arzneimittel |
US4455422A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and pharmaceutical composition containing the same |
WO2001032649A1 (de) * | 1999-10-29 | 2001-05-10 | Boehringer Ingelheim Pharma Kg | Arylalkane, arylalkene und aryl-azaalkane, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
WO2001032648A1 (de) * | 1999-10-29 | 2001-05-10 | Boehringer Ingelheim Pharma Kg | Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Also Published As
Publication number | Publication date |
---|---|
WO2009034029A2 (de) | 2009-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009065919A3 (de) | Organische verbindungen | |
WO2009065920A3 (de) | Verbindungen | |
WO2005103037A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
WO2009065922A3 (de) | Organische verbindungen | |
WO2007036532A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
TW200603799A (en) | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | |
TW200602338A (en) | Selected CGRP antagonists, process for preparing them and their use as pharmaceutical compositions | |
WO2004037811A8 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
WO2009034029A3 (de) | 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten | |
MY146623A (en) | Substituted prolinamides, manufacturing, and the use thereof as medicaments | |
WO2009013211A3 (en) | New pyrazol derivatives | |
RS20050311A (en) | Selected cgrp antagonists,method for production and use thereof as medicament | |
WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
TW200738692A (en) | New substituted glycinamides, process for their manufacture and use thereof as medicaments | |
WO2008116107A3 (en) | Piperazine derivatives as glucokinase activators | |
TW200738693A (en) | Substituted biaryls, process for their manufacture and use thereof as medicaments | |
WO2008022286A3 (en) | Small molecule inhibitors of kynurenine-3-monooxygenase | |
WO2009013299A3 (de) | Neue bradykinin b1-antagonisten | |
WO2007020261A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
NO20070089L (no) | DPP-IV inhibitorer | |
WO2007034279A3 (en) | C3a antagonists and pharmaceutical compositions thereof | |
TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
MX2010003849A (es) | Antagonistas de cgrp. | |
RS54413B1 (en) | [4- (5-AMINOMETHYL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL] - [7-FLUORO-1- (2-METHOXY-ETHYL) -4TRIFLUOROMETOXY-1H-INDOL-3-IL] METHANONE AS INHIBITOR MASTOCYT TRIPTASES | |
WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08803740 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08803740 Country of ref document: EP Kind code of ref document: A2 |